Salicylate activates AMPK and synergizes with metformin to reduce the survival of prostate and lung cancer cells ex vivo through inhibition of de novo lipogenesis. (Q38879155)
Jump to navigation
Jump to search
scientific article published on 5 May 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Salicylate activates AMPK and synergizes with metformin to reduce the survival of prostate and lung cancer cells ex vivo through inhibition of de novo lipogenesis. |
scientific article published on 5 May 2015 |
Statements
Salicylate activates AMPK and synergizes with metformin to reduce the survival of prostate and lung cancer cells ex vivo through inhibition of de novo lipogenesis (English)
Andrew J O'Brien
Linda A Villani
Vanessa P Houde
Giovanni Blandino
Theodoros Tsakiridis
Paola Muti
Gregory R Steinberg